Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brainHarry F. Dovey, B. Ni, Kang Hu et al.|Journal of Neurochemistry|2001Cited by 879
Amyloid precursor protein processing and Aβ <sub>42</sub> deposition in a transgenic mouse model of Alzheimer diseaseKelly Johnson‐Wood, Lisa McConlogue, M. Lee et al.|Proceedings of the National Academy of Sciences|1997Cited by 659
Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic MiceLisa McConlogue, Sukanto Sinha, Manuel Buttini et al.|Journal of Biological Chemistry|2007Cited by 294
Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous SystemKelly J. Inglis, John P. Anderson, David Chéreau et al.|Journal of Biological Chemistry|2008Cited by 274
A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer DiseaseRonald S. Black, Michael Grundman, Reisa A. Sperling et al.|Alzheimer Disease & Associated Disorders|2010Cited by 168